**Equity Swap Contract**

**General Terms**

This Equity Swap Contract is entered into between Party A (Party1) and Party B (Party2) on the Trade Date of 2001-09-24. The contract is governed by the ISDA Master Agreement and the Confirmation.

**Trade Details**

* Trade Identifier: 33f59567 and 33f59568
* Trade Date: 2001-09-24
* Effective Date: 2001-09-24
* Termination Date: 2002-09-24
* Mandatory Early Termination Date: Not applicable
* Notional Amount: USD 760400 and USD 28469376

**Product Details**

* Product Type: Equity Swap
* Underlying Security: Shire Pharmaceuticals Group - American Depositary Receipts (SHPGY.O)
* Return Type: Total
* Dividend Return Terms: ExDate, Extraordinary Dividends Party, Record Amount, and Dividend Currency determined by Dividend Currency
* Performance Payout: Party B pays Party A the difference between the total return of the underlying security and the total return of a notional investment in the underlying security

**Payment Terms**

* Party A payments: Party A pays Party B the difference between the total return of the underlying security and the total return of a notional investment in the underlying security
* Party B payments: Party B pays Party A the difference between the total return of the underlying security and the total return of a notional investment in the underlying security
* Payment Dates: Annually 2 Business Days after the Effective Date, commencing on 2001-10-12 and ending on 2002-09-24
* Business Day Convention: Following
* Day Count Fraction: ACT/360

**Calculation Agent**

* Calculation Agent: Party A (Party1)

**Governing Law**

* Governing Law: English

**Risk Disclosure**

* The parties acknowledge that there are significant risks associated with this Transaction, including but not limited to, foreign exchange risk, price risk, liquidity risk, and credit risk.

**Representations**

* Each party represents to the other party that it is acting for its own account and has made its own independent decisions to enter into this Transaction.

**Contract Details**

* Documentation: ISDA
* Dealer Name: Not applicable
* Client Type: Not applicable

**Scenario Analysis**

* The following Scenario Analysis is provided for illustrative and convenience purposes only:
	+ Scenario 1: USD SOFR-COMPOUND remains unchanged over the tenor of the trade
	+ Scenario 2: USD SOFR-COMPOUND increases over the tenor of the trade
	+ Scenario 3: USD SOFR-COMPOUND decreases over the tenor of the trade

**Mark to Market (MTM) Sensitivity Analysis**

* The following MTM Analysis is provided for illustrative and convenience purposes only:
	+ MTM Sensitivity due to parallel shift in USD SOFR-COMPOUND Curve immediately after Trade Date
	+ MTM Sensitivity due to parallel shift in USD SOFR-COMPOUND Curve as on Mandatory Termination Date compared to Trade Date

**Level of Pricing Variables and Impact of Variables on Pricing**

* The following analysis is provided for information and illustrative purposes only:
	+ USD 10 year SOFR-COMPOUND Rate: 4.427%
	+ Primary market variables used for determining the mark-to-market value along with their directional impact are listed below for information purposes only and is subject to change.